Conference Coverage

Obesity linked to RA disease activity, disability


 

AT ACR 2017

– In what may be the largest study of its kind, British researchers have linked obesity to significantly higher odds of rheumatoid arthritis disease activity and disability.

Dr. Elena Nikiphorou

Dr. Elena Nikiphorou

It’s not surprising that obesity and RA are linked, but the connection is more complex than may be expected. “Epidemiologic studies suggest that obesity may be associated with a modestly increased risk for the development of RA, although these studies have shown conflicting results,” wrote Michael D. George, MD, and Joshua F. Baker, MD, both of the University of Pennsylvania, Philadelphia, in a 2016 report. “Among patients with established RA, obesity has been observed to be associated with greater subjective measures of disease activity and poor treatment response, but also with a decreased risk of joint damage and lower mortality.” (Curr Rheumatol Rep. 2016 Jan;18[1]:6.)

Despite obesity having been tied to decreased joint damage in established RA, Eric L. Matteson, MD, noted in an interview, that“the biomechanical effect of [being] overweight, especially on the weight-bearing joints” is one of the two “especially important” mechanisms explaining the link between RA and obesity. “The other is that fat cells produce inflammatory proteins, which contribute to the disease process and make it more difficult to treat,” said Dr. Matteson, a rheumatologist at the Mayo Clinic, Rochester, Minn.

“In my view the mechanical risk to the joint outweighs any possible ‘protective’ effect of RA,” Dr. Matteson added in an interview.

At baseline, 37.2% of 2,420 patients (90% of total) were overweight, and 21.3% were obese. Average body mass index (BMI) rose between the two consecutive studies from 25.5 to 27.6.

The researchers found that obesity was linked to lower likelihoods of remission and low disease activity status (odds ratio, 0.71; 95% confidence interval, 0.55-0.93 and OR, 0.69; 95% CI, 0.55-0.87, respectively.) After controlling for factors such as age and gender, they also saw slightly lower odds of remission in those with higher BMI (OR, 0.97; 95% CI, 0.95-0.99). But there was no statistically significant link between higher BMI and low disease activity status.

The study also connected obesity to higher odds of disability (OR, 1.63; 95% CI, 1.20-2.23). Furthermore, higher BMI was linked to higher odds of disability (OR, 1.04; 95% CI, 1.01-1.06).

Study lead author Dr. Nikiphorou, who spoke in an interview and in comments at an ACR press conference, said “this study emphasizes that obesity can have a profound effect on treatment goals in rheumatoid arthritis. It creates a strong case for addressing BMI and addressing obesity, flagging it up to primary care.”

She added that rheumatologists too often focus on only rheumatoid conditions. “We place so much evidence on disease activity scores,” she said. “How often do we really address the patient in terms of other things going on, including obesity? What we can do is include discussion of BMI, exercise, nutrition.”

Dr. Nikiphorou and Dr. Matteson report no relevant disclosures. No specific study funding is reported.

Recommended Reading

Immunogenicity concerns for biosimilars so far don’t go beyond originator biologics
MDedge Internal Medicine
Launch of adalimumab biosimilar Amjevita postponed
MDedge Internal Medicine
Too few RA patients get timely adjustment of DMARDs
MDedge Internal Medicine
Flu shots and persuasion
MDedge Internal Medicine
High ‘nocebo’ effect observed when patients knowingly switch to a biosimilar
MDedge Internal Medicine
Rheumatoid arthritis increases risk of COPD hospitalizations
MDedge Internal Medicine
Biosimilars poised to save $54 billion over the next decade
MDedge Internal Medicine
In close vote, advisory panel prefers Shingrix over Zostavax
MDedge Internal Medicine
VIDEO: Biologic use during pregnancy had no impact on serious infection risks in infants
MDedge Internal Medicine
Methotrexate holiday linked to better flu vaccine immunogenicity
MDedge Internal Medicine